These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
212 related items for PubMed ID: 26428372
1. The EBNA3 Family: Two Oncoproteins and a Tumour Suppressor that Are Central to the Biology of EBV in B Cells. Allday MJ, Bazot Q, White RE. Curr Top Microbiol Immunol; 2015; 391():61-117. PubMed ID: 26428372 [Abstract] [Full Text] [Related]
2. Epstein-Barr Virus Nuclear Antigen 3 (EBNA3) Proteins Regulate EBNA2 Binding to Distinct RBPJ Genomic Sites. Wang A, Welch R, Zhao B, Ta T, Keleş S, Johannsen E. J Virol; 2015 Dec 30; 90(6):2906-19. PubMed ID: 26719268 [Abstract] [Full Text] [Related]
3. Epstein-Barr Virus (EBV) Latent Protein EBNA3A Directly Targets and Silences the STK39 Gene in B Cells Infected by EBV. Bazot Q, Paschos K, Allday MJ. J Virol; 2018 Apr 01; 92(7):. PubMed ID: 29367247 [Abstract] [Full Text] [Related]
4. EBNA2 and Its Coactivator EBNA-LP. Kempkes B, Ling PD. Curr Top Microbiol Immunol; 2015 Apr 01; 391():35-59. PubMed ID: 26428371 [Abstract] [Full Text] [Related]
5. An EBNA3A-Mutated Epstein-Barr Virus Retains the Capacity for Lymphomagenesis in a Cord Blood-Humanized Mouse Model. Romero-Masters JC, Ohashi M, Djavadian R, Eichelberg MR, Hayes M, Zumwalde NA, Bristol JA, Nelson SE, Ma S, Ranheim EA, Gumperz JE, Johannsen EC, Kenney SC. J Virol; 2020 May 04; 94(10):. PubMed ID: 32132242 [Abstract] [Full Text] [Related]
6. EBV epigenetically suppresses the B cell-to-plasma cell differentiation pathway while establishing long-term latency. Styles CT, Bazot Q, Parker GA, White RE, Paschos K, Allday MJ. PLoS Biol; 2017 Aug 04; 15(8):e2001992. PubMed ID: 28771465 [Abstract] [Full Text] [Related]
7. The EBNA3 family of Epstein-Barr virus nuclear proteins associates with the USP46/USP12 deubiquitination complexes to regulate lymphoblastoid cell line growth. Ohashi M, Holthaus AM, Calderwood MA, Lai CY, Krastins B, Sarracino D, Johannsen E. PLoS Pathog; 2015 Apr 04; 11(4):e1004822. PubMed ID: 25855980 [Abstract] [Full Text] [Related]
8. Epstein-Barr virus nuclear antigen 3A partially coincides with EBNA3C genome-wide and is tethered to DNA through BATF complexes. Schmidt SC, Jiang S, Zhou H, Willox B, Holthaus AM, Kharchenko PV, Johannsen EC, Kieff E, Zhao B. Proc Natl Acad Sci U S A; 2015 Jan 13; 112(2):554-9. PubMed ID: 25540416 [Abstract] [Full Text] [Related]
9. Extensive co-operation between the Epstein-Barr virus EBNA3 proteins in the manipulation of host gene expression and epigenetic chromatin modification. White RE, Groves IJ, Turro E, Yee J, Kremmer E, Allday MJ. PLoS One; 2010 Nov 15; 5(11):e13979. PubMed ID: 21085583 [Abstract] [Full Text] [Related]
10. RNA Sequencing Analyses of Gene Expression during Epstein-Barr Virus Infection of Primary B Lymphocytes. Wang C, Li D, Zhang L, Jiang S, Liang J, Narita Y, Hou I, Zhong Q, Zheng Z, Xiao H, Gewurz BE, Teng M, Zhao B. J Virol; 2019 Jul 01; 93(13):. PubMed ID: 31019051 [Abstract] [Full Text] [Related]
11. The Cooperative Functions of the EBNA3 Proteins Are Central to EBV Persistence and Latency. Styles CT, Paschos K, White RE, Farrell PJ. Pathogens; 2018 Mar 17; 7(1):. PubMed ID: 29562595 [Abstract] [Full Text] [Related]
12. EBV persistence without its EBNA3A and 3C oncogenes in vivo. Murer A, McHugh D, Caduff N, Kalchschmidt J, Barros M, Zbinden A, Capaul R, Niedobitek G, Allday M, Chijioke O, Münz C. PLoS Pathog; 2018 Apr 17; 14(4):e1007039. PubMed ID: 29709016 [Abstract] [Full Text] [Related]
13. Epigenetic repression of p16(INK4A) by latent Epstein-Barr virus requires the interaction of EBNA3A and EBNA3C with CtBP. Skalska L, White RE, Franz M, Ruhmann M, Allday MJ. PLoS Pathog; 2010 Jun 10; 6(6):e1000951. PubMed ID: 20548956 [Abstract] [Full Text] [Related]
14. EBNA1. Frappier L. Curr Top Microbiol Immunol; 2015 Jun 10; 391():3-34. PubMed ID: 26428370 [Abstract] [Full Text] [Related]
15. Epstein-Barr virus protein EBNA-LP engages YY1 through leucine-rich motifs to promote naïve B cell transformation. Cable JM, Reinoso-Vizcaino NM, White RE, Luftig MA. PLoS Pathog; 2024 Jul 10; 20(7):e1011950. PubMed ID: 39083560 [Abstract] [Full Text] [Related]
16. Potential cellular functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr Virus. Westhoff Smith D, Sugden B. Viruses; 2013 Jan 16; 5(1):226-40. PubMed ID: 23325328 [Abstract] [Full Text] [Related]
17. Dissecting the contribution of EBNA3C domains important for EBV-induced B-cell growth and proliferation. Jha HC, Shukla SK, Lu J, Aj MP, Banerjee S, Robertson ES. Oncotarget; 2015 Oct 06; 6(30):30115-29. PubMed ID: 26336822 [Abstract] [Full Text] [Related]
18. Epstein-Barr virus-encoded Bcl-2 homologue functions as a survival factor in Wp-restricted Burkitt lymphoma cell line P3HR-1. Watanabe A, Maruo S, Ito T, Ito M, Katsumura KR, Takada K. J Virol; 2010 Mar 06; 84(6):2893-901. PubMed ID: 20042495 [Abstract] [Full Text] [Related]
19. Core binding factor (CBF) is required for Epstein-Barr virus EBNA3 proteins to regulate target gene expression. Paschos K, Bazot Q, Ho G, Parker GA, Lees J, Barton G, Allday MJ. Nucleic Acids Res; 2017 Mar 17; 45(5):2368-2383. PubMed ID: 27903901 [Abstract] [Full Text] [Related]
20. EBNA3C facilitates RASSF1A downregulation through ubiquitin-mediated degradation and promoter hypermethylation to drive B-cell proliferation. Zhang S, Pei Y, Lang F, Sun K, Singh RK, Lamplugh ZL, Saha A, Robertson ES. PLoS Pathog; 2019 Jan 17; 15(1):e1007514. PubMed ID: 30615685 [Abstract] [Full Text] [Related] Page: [Next] [New Search]